Skip Navigation
Skip to contents

Ann Clin Nutr Metab : Annals of Clinical Nutrition and Metabolism

OPEN ACCESS

Articles

Page Path
HOME > Ann Clin Nutr Metab > Volume 17(1); 2025 > Article
Original Article Perioperative outcomes of older adult patients with pancreatic cancer based on nutritional status: a retrospective cohorat study
Takanori Morikawa,*orcid, Masaharu Ishidaorcid, Masamichi Mizumaorcid, Kei Nakagawaorcid, Takashi Kameiorcid, Michiaki Unnoorcid
Annals of Clinical Nutrition and Metabolism 2025;17(1):66-74.
DOI: https://doi.org/10.15747/ACNM.25.001
Published online: April 1, 2025

Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan

Corresponding author: Takanori Morikawa email: takanori-morikawa@miyagi-pho.jp

Current affiliation: Department of Gastroenterological Surgery, Miyagi Cancer Center, Natori, Japan

This article is a secondary publication of the article in Japanese published in the Japanese Journal of Surgical Metabolism and Nutrition, 2022;56(1):30-36. https://doi.org/10.11638/jssmn.56.1_30. The editors of both journals have granted permission for secondary publication.

The context of this article was summarized and presented in the 57th Annual Meeting of the Japanese Surgical Metabolism and Nutrition held in 2020.

• Received: October 27, 2024   • Revised: November 14, 2024   • Accepted: November 28, 2024

© 2025 Korean Society of Surgical Metabolism and Nutrition · Korean Society for Parenteral and Enteral Nutrition · Asian Society of Surgical Metabolism and Nutrition · Japanese Society for Surgical Metabolism and Nutrition

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 97 Views
  • 2 Download
prev next
  • Purpose
    This study investigated the effects of preoperative nutritional status on postoperative outcomes in older adult patients with pancreatic adenocarcinoma.
  • Methods
    The background and perioperative factors of patients who underwent pancreatectomy for pancreatic adenocarcinoma between 2007 and 2020 were retrospectively analyzed.
  • Results
    Patients aged 75 years or over (older adults) were significantly associated with hypertension, upfront surgery, and lower prognostic nutritional index. In addition, these patients had a significantly lower rate of portal vein resection, less blood loss, and shorter operation time than patients aged less than 75 years (non-older adults). During the postoperative course, older adult patients had a higher rate of pneumonia and lower overall survival than younger patients, although recurrence‐free survival was comparable. In addition, older adult patients showed preoperative malnutrition as a risk factor for postoperative in‐hospital death.
  • Conclusion
    Surgical treatment for pancreatic cancer in older adult patients was performed safely. However, preoperative malnutrition is a risk factor for in‐hospital death and such patients require nutritional support and less‐invasive surgery.
Background
Japan has entered a full-fledged aging society with a declining birthrate. The late-stage older adult population accounted for 17.48 million, or 13.8% of the total population, in fiscal year 2009 [1]. The incidence of pancreatic cancer and biliary tract cancer has been increasing in recent years, and it is not uncommon to perform difficult hepatobiliary and pancreatic surgery on older adult patients. Although the application of highly invasive hepatobiliary and pancreatic surgery requires sufficient verification, there is no clear indicator to determine the indication for surgery in older adult patients, which is currently left to the attending physician or each institution.
Objectives
The CONUT value [2] and Onodera's prognostic nutritional index (PNI) [3] are nutritional indices that can be calculated from daily blood sampling data, are easy to use, and can be performed at general facilities. We selected these two indicators and investigated their usefulness as perioperative risk assessment factors for the nutritional status of older adult (≥75 years) and non-older adult (<75 years) patients with pancreatic cancer.
Ethics statement
This study was approved by the Ethics Committee of Tohoku University Graduate School of Medicine (2020-1-322) as a “Study of clinicopathologically relevant factors and treatment outcomes in pancreatic diseases." The written informed consent was waived because this design is a retrospective study.
Study design
It is a retrospective cohort study. It was described according to the STOBE statement available at: https://www.strobe-statement.org/.
Setting
This study was done at Tohoku University Hospital between January 2007 and June 2020. Surgical procedure for pancreatic cancer patients were as follows:
The standard pancreaticoduodenectomy (PD) for pancreatic cancer in our department is a subtotal stomach-sparing PD in which the stomach is orally dissected 2-4 cm from the pyloric ring and standard lymph node dissection. The modified Child method is used for reconstruction, and the Blumgart method is mainly used for pancreaticojejunostomy since 2016, although the two-layer pancreaticojejunostomy was used until 2015 [4]. An enteral feeding tube is also implanted and postoperative enteral nutrition is used. Distal pancreatectomy (DP) with standard lymph node dissection, dividing the pancreas just above the portal vein, is the basic approach for pancreatic cancer. In open DP, the main pancreatic duct is double ligated and the pancreatic stump is closed in a fish-mouth fashion; however, in laparoscopic surgery, the stump is closed with an automatic suturing device.
Participants
We included 549 patients with pancreatic cancer who underwent resection in the Department of General Surgery, Tohoku University Hospital between January 2007 and June 2020. A total of 122 patients (22.2%) were aged 75 years or older (older adult group) with the remaining 427 patients (77.8%) aged less than 75 years (non-older adult group).
Variables
The following background factors, intraoperative factors, and postoperative outcomes of the older adult and non-older adult groups were reviewed in the medical records and our department database for retrospective evaluation. Background factors included age, sex, comorbidities (hypertension, diabetes), preoperative chemotherapy, stage of disease, and preoperative nutritional indices such as PNI and CONUT values. Intraoperative factors included surgical technique, portal vein resection, operative time, blood loss, and R0 resection. The postoperative outcome measures included all complications, major complications, hospital mortality, postoperative pancreatic fistula, surgical site infection (SSI), organ space SSI, pneumonia, sepsis, thrombosis, postoperative hospital stay, readmission within 30 days, overall survival, and recurrence-free survival. Severe complications were defined as IIIa or higher of the Clavien-Dindo classification [5], and postoperative pancreatic fistula was defined according to the criteria of the revised International Study Group on Pancreatic Surgery [6]. Staging was described in accordance with the 7th edition of the General Rules for the Study of Pancreatic Cancer [7]. Patients were followed up every 3 months after surgery as outpatients, and the presence or absence of recurrence was confirmed mainly by imaging tests. Overall survival and recurrence-free survival were defined as the period from the date of surgery to the date of death, the date of recurrence confirmation, or the date of the last outpatient visit, with the date of recurrence confirmation being the date when recurrence was confirmed by imaging tests. Recurrence-free survival was terminated in the case of death without recurrence.
Bias
There was no selection bias reportable.
Data sources
Data were from the patient’s medical records.
Measurements
We compared the background, intraoperative, and postoperative factors between the older adult and non-older adult patients, and confirmed the background and perioperative characteristics of older adult patients undergoing pancreatic cancer resection. The PNI and CONUT values were calculated using the following formula, and patients with PNI less than 40 were classified as malnourished.
PNI=10×(albumin value)+0.005×(total lymphocyte count), CONUT values [2] were calculated as shown in Fig. 1.
A score of 0 to 1 is normal, 2 to 4 is mildly abnormal, 5 to 8 is moderately abnormal, and 9 or more is severely abnormal. In this study, patients with moderate or severe abnormalities with a CONUT value of 5 or higher were defined as malnourished.
Study size
Since all target patients were recruited and included according to the selection criteria, no sample size estimation was done.
Statistical methods
Continuous variables are presented as the mean±standard deviation if they followed a normal distribution, or as the median and range if they did not. For nominal variables, either the chi-square test or the Fisher direct probability calculation method was used. Survival rates were statistically analyzed using the log-rank test with the Kaplan-Meier method. A P-value of less than 0.05 was defined as statistically significant.
Characteristics of resected pancreatic cancer cases in older adult patients
A comparison of background factors showed that 80 (65.5%, P<0.001) of the patients in the older adult group had coexisting hypertension, and the number of patients who received pre-operative chemotherapy was significantly lower (P<0.001) (Table 1). Preoperative CONUT values were not significantly different between the two groups, but preoperative PNI was 43.0±5.7 in the older adult group, which was significantly lower (P=0.032). There was no difference in stage between the two groups. On the other hand, DP was performed significantly higher in the older adult group than in the non-older adult group (P=0.007), with total pancreatectomy (TP) being less common in the older adult group. In addition, 33 patients underwent combined portal vein resection (27.1%, P<0.001), and operative time and blood loss were also significantly lower than patients in the non-older adult group (P<0.001 for each).
When examining the postoperative course, there was no difference in overall postoperative complications or major complications, and postoperative pancreatic fistula tended to be more common in the older adults, but with no significant difference (P=0.058) (Table 2).
Postoperative pneumonia occurred in 13 patients in the older adult group (10.6%), which was significantly higher than that in the non-older adult group (P=0.02). Long-term prognosis showed that overall survival was significantly lower in the older adult group than in the non-older adult (P=0.002) (Fig. 2A). However, there was no significant difference in recurrence-free survival (Fig. 2B).
Perioperative outcomes based on nutritional indices
Nutritional disorders were defined in 36 (29.5%) of the 122 older adult patients using PNI, and 31 (25.4%) were identified by CONUT values. Comparing the cases of pancreatic cancer resection in the older adult group between PNI 40 or less and the other groups, there was no difference in background factors, but there were seven cases of preoperative chemotherapy in the PNI 40 or less group (19.4%), which was significantly less (P=0.022) (Table 3). Although postoperative outcomes were similar, mortality after pancreatectomy was significantly higher in the PNI 40 or less group, with three (8.3%) deaths in the hospital (P=0.042) (Table 4).
On the other hand, in the CONUT classification, the group with nutritional disorders did not differ from the group without nutritional disorders in terms of background factors (Table 5). However, as with the PNI classification, postoperative mortality was significantly higher in patients with nutritional disorder (P<0.001) (Table 6). The four deaths among older adult patients were all due to infectious complications, except for one death due to primary disease, but no other trends were observed (Table 7). In these patients, there were one case of high intraoperative blood loss due to invasive surgery including portal vein and celiac axis resection, and two cases of postoperative pancreatic fistula, which resulted in infectious complications.
Key results
Older adult patients with pancreatic cancer after resection had more hypertension (65.5%) and received less preoperative chemotherapy than non-older adult patients. Preoperative PNI was lower (43.0±5.7), but CONUT values were similar. Surgeries were less extensive, with shorter duration and less blood loss. Postoperative pneumonia incidence and overall mortality were significantly higher among older adult patients, though recurrence-free survival was similar. Nutritional disorders, defined by low PNI or CONUT values, significantly correlated with increased postoperative mortality, primarily due to infectious complications, including pancreatic fistula.
Interpretation/comparison with previous studies
Pancreatectomy, including PD and TP, is a difficult and highly invasive procedure that requires careful management in older adult patients. The risk of pancreatic fistula is particularly high in PD, and the incidence of postoperative complications and mortality rates are reported to be 41.6% and 2.8%, respectively, even with the improvement of surgical techniques and the development of perioperative management [8]. However, there are an increasing number of reports in recent years showing that PD for the older adult has comparable postoperative outcomes to those for younger patients [9,10]. In this study, we compared the postoperative results between older adult and non-older adult patients, and found that pancreatectomy can be performed safely in older adult patients as in previous reports. However, the older adult patients had lower preoperative PNI, more nutritional problems, and more preoperative comorbidities. On the other hand, the perioperative results showed that the postoperative outcome of the older adult patients was relatively good, even if they had preoperative nutritional problems. Although the influence of preoperative patient selection is undeniable, it is also possible that the incidence of postoperative complications was reduced by shifting to less invasive procedures and by efforts to reduce blood loss and operation time. Even so, not all complications were controlled, and postoperative pneumonia was more common in the older adult group.
The incidence of postoperative pneumonia in the older adult was significantly higher than that in the non-older adult group. Prevention of postoperative pneumonia in the older adult requires not only reduction of surgical invasiveness but also more multifaceted medical care. The effectiveness of oral care in reducing postoperative infectious complications after PD surgery [11] and the introduction of a perioperative management team in preventing pneumonia [12] have been reported, suggesting that there is room for further improvement in the prevention of postoperative pneumonia in older adult patients with pancreatic cancer.
In a study of long-term prognosis in older adult patients with pancreatic cancer, overall survival was significantly lower than that in non-older adult patients, but recurrence-free survival was similar. Although it is difficult to make a generalized statement because the study did not match the surgical technique and stage, the overall survival rate was probably influenced by the median age (78 years) and comorbidities in the older adult group. On the other hand, there was no difference in recurrence-free survival or R0 resection rate, suggesting that surgical resection for pancreatic cancer in the older adult is comparable to that in the non-older adults. In addition, it is interesting to note that preoperative chemotherapy was administered at a significantly lower rate in older adult patients with pancreatic cancer. Currently, the standard treatment for resectable pancreatic cancer is pre-operative chemotherapy with gemcitabine plus S1 and surgical resection, but the PREP-02/JSAP-05 trial, on which this standard is based, did not enroll patients aged 80 or older [13]. Although the long-term prognosis was not examined in our study, 39 (31.9%) of the patients in the late-stage older adult group were aged 80 years or older.
Considering that the outcomes of resected patients are similar, it is possible that preoperative chemotherapy is unnecessary for patients over 80 years of age. The necessity of preoperative treatment for pancreatic cancer patients over 80 years of age should also be considered in the future. In addition, among resected pancreatic cancer patients in the older adults, significantly more patients with a PNI of 40 or less did not receive preoperative chemotherapy. Although our institution does not conduct nutritional assessment as a preoperative treatment criterion for pancreatic cancer, it is possible that patients were selected a priori based on nutritional assessment. In this sense, the significance of nutritional evaluation as a requirement for preoperative treatment of pancreatic cancer in the older adults may be significant.
In older adult patients with pancreatic cancer, preoperative nutritional disorders were considered a risk factor for post-operative hospital mortality, although they did not affect other complications. Ishida et al. [14] compared preoperative nutritional status and postoperative complications in PD and reported that postoperative complications were significantly more frequent in patients with preoperative nutritional problems than in normal patients when the effect of pancreatic fistula was excluded. Older adult patients have a decline in immune function associated with aging, and aging has been cited as a poor prognostic factor in patients with sepsis [1]. Yanagawa et al. [15] also studied gastric cancer patients with pyloric stenosis, and reported that poor preoperative nutrition was associated with a high risk of postoperative infectious complications. In this report, three out of four patients who died in the hospital also had infectious complications, suggesting that older adult patients with preoperative malnutrition who underwent pancreatic cancer resection are more prone to infectious complications and more likely to develop serious complications.
It is also interesting to note that in this comparison between older adult and non-older adult patients, the older adult patients had significantly lower PNI, whereas no difference was observed in CONUT scores. Although both PNI and CONUT included albumin and total lymphocyte counts as calculation factors, total cholesterol, which is considered an indicator of lipid metabolism, was included only in CONUT. Nutritional improvement has been reported by administering pancrelipase to patients with pancreatic exocrine insufficiency [16], and the effect on pancreatic cancer patients may be equivalent to that of pancrelipase. Early administration of pancrelipase in pancreatic cancer patients may improve preoperative nutritional status and postoperative outcomes.
Limitations
It was a single-center, retrospective study and that surgical treatment was likely to have been performed only in selected patients with older adult disease. In addition, we did not include any nutritional indices such as muscle mass, performance status, hypertension, and diabetes mellitus in this study. However, it is also true that a simpler and more objective evaluation index is required in daily clinical practice, and the development of a more versatile index is expected in the future.
Conclusion
We examined cases of pancreatic cancer resection in the older adults, and found that surgical treatment was safe and less invasive, although many patients with pancreatic cancer in the older adults were accompanied by nutritional disorders. However, preoperative malnutrition is a risk factor for in-hospital mortality, and it is necessary to take measures such as improving malnutrition and avoiding over-invasive surgery.
Fig. 1.
CONUT value calculation table.
ACNM-25-001f1.jpg
Fig. 2.
Long-term outcomes after pancreatic cancer resection in older adult (≥75 yeasr) and non-older (<75 years) patients. Comparing patients aged ≥75 years with those aged <75 years, the overall survival rate was significantly better in patients aged <75 years (P=0.002) (A). However, the two groups had no significant difference in recurrence-free survival (P=0.198) (B).
ACNM-25-001f2.jpg
Table 1.
Comparison of the background and intraoperative factors between the elderly and non-elderly patients
<75 yr ≥75 yr P-value
Sex (male:female) 253:174 69:53 0.594
Preoperative CONUT value 2 (0-11) 3 (0-9) 0.260
Preoperative PNI 44.3±6.0 43.0±5.7 0.032a
Diabetes mellitus 220 (51.5) 61 (50.0) 0.837
Hypertension 199 (46.6) 80 (65.5) <0.001a
Preoperative chemotherapy 230 (53.8) 43 (35.3) <0.001a
Stage of an illness 0 3 (0.7) 2 (1.6) 0.070
IA 29 (6.8) 8 (6.6)
IB 7 (1.6) 1 (0.8)
IIA 98 (22.9) 43 (35.2)
IIB 233 (54.6) 60 (49.2)
III 5 (1.2) 0
IV 52 (12.2) 8 (6.6)
Operative procedure PD 248 (58.1) 61 (50.0)
DP 118 (27.6) 51 (41.8) 0.007a
TP 61 (14.3) 10 (8.2)
Combined portal vein resection 172 (40.3) 33 (27.1) 0.008a
Operation time (min) 534 (150–1,160) 481 (182–851) <0.001a
Amount of blood loss (mL) 1,179 (22–7,250) 906 (63–9,695) <0.001a
R0 resection 358 (83.8) 100 (82.0) 0.597

Values are presented as median (range), mean±SD, or number (%).

PNI, prognostic nutritional index; PD, pancreaticoduodenectomy; DP, distal pancreatectomy; TP, total pancreatectomy; SD, standard deviation.

aStatistically significant differences.

Table 2.
Comparison of postoperative results between resected pancreatic cancer cases in elderly and non-elderly patients
<75 yr ≥75 yr P-value
Postoperative hospital stay (day) 24 (5–193) 25 (3–415) 0.858
Total complications 328 (76.8) 87 (71.3) 0.232
Serious complications 121 (28.3) 36 (29.5) 0.820
Death in hospital 11 (2.5) 4 (3.2) 0.752
Readmission within 30 day 19 (15.5) 54 (12.6) 0.613
SSI 106 (24.8) 36 (29.5) 0.294
Organ space SSI 71 (16.6) 24 (19.6) 0.419
Postoperative pancreatic fistula 56 (13.1) 25 (20.4) 0.058
Postoperative pneumonia 21 (4.9) 13 (10.6) 0.020a
Septicemia 26 (6.0) 6 (4.9) 0.826
Thrombosis 22 (5.7) 7 (5.1) 0.818

Values are presented as median (range) or number (%).

SSI, surgical site infection.

aStatistically significant differences.

Table 3.
Background and intraoperative factors of late-stage elderly pancreatic cancer cases grouped by PNI40
PNI≤40 PNI>40 P-value
Sex (male:female) 24:12 45:41 0.165
Hypertension 26 (72.2) 54 (62.8) 0.404
Diabetes mellitus 19 (52.8) 42 (48.8) 0.842
Preoperative chemotherapy 7 (19.4) 36 (41.8) 0.022a
Operative procedure PD 21 (58.3) 40 (46.5) 0.536
DP 14 (38.9) 37 (43.0)
TP 1 (2.8) 9 (10.5)
Combined portal vein resection 12 (33.3) 21 (24.4) 0.372
Operation time (min) 502 (182–851) 470 (202–845) 0.306
Amount of blood loss (mL) 1,222 (82–9,639) 834 (63–9,695) 0.149
R0 resection 28 (77.8) 72 (83.7) 0.529

Values are presented as number (%) or median (range).

PNI, prognostic nutritional index; PD, pancreaticoduodenectomy; DP, distal pancreatectomy; TP, total pancreatectomy.

aStatistically significant differences.

Table 4.
Postoperative outcomes of older adult patients with pancreatic cancer grouped by PNI40
PNI≤40 PNI>40 P-value
Postoperative hospital stay (day) 27.5 (3–163) 24 (10–415) 0.355
Total complications 28 (77.8) 59 (68.6) 0.382
Serious complications 14 (38.9) 22 (25.6) 0.191
Death in hospital 3 (8.3) 1 (1.2) 0.042a
Readmission within 30 day 3 (8.3) 16 (18.6) 0.181
SSI 12 (33.3) 24 (27.9) 0.663
Organ space SSI 8 (22.2) 16 (18.6) 0.627
Postoperative pancreatic fistula 7 (19.4) 18 (20.9) 0.852
Postoperative pneumonia 6 (16.1) 7 (8.1) 0.200
Septicemia 1 (2.7) 5 (5.8) 0.669
Thrombosis 4 (11.1) 3 (3.5) 0.193

Values are presented as median (range) or number (%).

PNI, prognostic nutritional index; SSI, surgical site infection.

aStatistically significant differences.

Table 5.
Background and intraoperative factors of older adult patients with pancreatic cancer grouped by CONUT values
No nutritional disorders Nutritional disorders P-value
Sex (male:female) 48:43 21:10 0.207
Hypertension 21 (67.7) 59 (64.8) 0.829
Diabetes mellitus 17 (54.8) 44 (48.3) 0.677
Preoperative chemotherapy 35 (38.5) 8 (25.8) 0.276
Operative procedure PD 43 (47.2) 18 (58.1) 0.388
DP 39 (42.9) 12 (38.7)
TP 9 (9.9) 1 (3.2)
Combined portal vein resection 24 (26.4) 9 (29.0) 0.816
Operation time (min) 471 (202–845) 498 (182–851) 0.462
Amount of blood loss (mL) 870 (63–9,695) 1,145 (82–9,639) 0.432
R0 resection 76 (83.5) 24 (77.4) 0.565

Values are presented as number (%) or median (range).

PD, pancreaticoduodenectomy; DP, distal pancreatectomy; TP, total pancreatectomy.

Table 6.
Postoperative outcomes of older adult patients with pancreatic cancer grouped by CONUT value
No nutritional disorders Nutritional disorders P-value
Postoperative hospital stay (day) 24 (10–415) 28 (3–100) 0.085
Total complications 61 (67.0) 26 (83.8) 0.106
Serious complications 25 (27.5) 11 (35.5) 0.494
Death in hospital 0 4 (12.9) <0.001a
Readmission within 30 day 17 (18.7) 2 (6.5) 0.151
SSI 25 (27.4) 11 (35.5) 0.494
Organ space SSI 18 (19.8) 6 (19.4) 0.958
Postoperative pancreatic fistula 20 (21.9) 5 (16.1) 0.799
Postoperative pneumonia 8 (8.8) 5 (16.1) 0.312
Septicemia 4 (4.4) 2 (6.4) 0.643
Thrombosis 5 (5.5) 2 (6.5) 0.845

Values are presented as median (range) or number (%).

SSI, surgical site infection.

aStatistically significant differences.

Table 7.
Pancreatic cancer in-hospital deaths in older adult patients
Age Sex Technique PVR Blood loss (mL) Operation time (min) Postoperative pancreatic fistula PNI CONUT Cause of death
1 76 Male DP None 9,639 453 Yes 37.1 5 Renal failure, pneumonia
2 75 Male DP-CAR None 350 535 None 41.4 5 Pancreatic cancer liver metastasis
3 79 Women SSPPD None 545 531 Yes 29.7 8 Sepsis
4 82 Male SSPPD, right colon resection Yes 1,483 529 None 36.7 6 Sepsis, ARDS

PVR, portal vein combined resection; PNI, prognostic nutritional index; DP, distal pancreatectomy; DP-CAR, distal pancreatectomy with celiac axis resection; SSPPD, subtotal stomach-preserving pancreaticoduodenectomy; ARDS, acute respiratory distress syndrome.

  • 1. Inoue S. Classification of postoperative organ failure. JSSEM 2021;55:6-10. ArticlePubMed
  • 2. Ignacio de Ulibarri J, Gonzalez-Madrono A, de Villar NG, Gonzalez P, Gonzalez B, Mancha A, et al. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp 2005;20:38-45. PubMed
  • 3. Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. J Jpn Surg Soc 1984;85:1001-1005.PDF
  • 4. Fujii T, Sugimoto H, Yamada S, Kanda M, Suenaga M, Takami H, et al. Modified Blumgart anastomosis for pancreaticojejunostomy: technical improvement in matched historical control study. J Gastrointest Surg 2014;18:1108-15. ArticlePubMedPDF
  • 5. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009;250:187-96. ArticlePubMed
  • 6. Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery 2017;161:584-91. ArticlePubMed
  • 7. Japan Pancreas Society. Classification of pancreatic carcinoma. Kanehara & Co., Ltd.; 2016.PDF
  • 8. Aoki S, Miyata H, Konno H, Gotoh M, Motoi F, Kumamaru H, et al. Risk factors of serious postoperative complications after pancreaticoduodenectomy and risk calculators for predicting postoperative complications: a nationwide study of 17,564 patients in Japan. J Hepatobiliary Pancreat Sci 2017;24:243-51. ArticlePubMedPMCPDF
  • 9. Sugawara S, Watanabe T, Tezuka K, Hirai I, Kimura W. Surgical outcomes of pancreaticoduodenectomy and postoperative changes in nutritional indexes in elderly patients over 75. Nihon Rinsho Geka Gakkai Zasshi 2018;79:267-72. Article
  • 10. Murakami M, Shimizu J, Koga C, Hitora T, Kawabata R, Oda N, et al. Analysis of pancreaticoduodenectomy for elderly patients aged 75 years or older. Gan To Kagaku Ryoho 2015;42:2351-3. PubMed
  • 11. Nobuhara H, Shinji Y, Ito K, Itamoto T. Preventive effect of perioperative oral care on postoperative infectious complications of gastrointestinal cancer. JSSEM 2017;51:165-74. ArticlePubMed
  • 12. Okamura A, Watanabe M, Imamura Y, Kamiya S, Hayami M, Yamashita K, et al. Current status of postoperative recurrent nerve palsy after thoracoscopic esophagectomy and significance of perioperative management team in prevention of postoperative pneumonia. Jpn J Tracheoesophageal Sci 2017;68:189-91. Article
  • 13. Motoi F, Kosuge T, Ueno H, Yamaue H, Satoi S, Sho M, et al. Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05). Jpn J Clin Oncol 2019;49:190-4. ArticlePubMed
  • 14. Ishida M, Motoi F, Sato H, Murakami M, Maeda S, Kudoh K, et al. Preoperative nutritional assessment by CONUT (Controlling Nutritional Status) and postoperative complications after pancreatoduodenectomy. J JSPEN 2018;33:641-6. Article
  • 15. Yanagawa T, Iwazawa T, Fujita J, Kawanishi K, Kawanishi K, Nagai K, et al. Preoperative nutritional status and postoperative infectious complications in gastric cancer patients with pyloric stenosis. JSSEM 2013;47:139-45. ArticlePubMed
  • 16. Miyoshi H, Inui W, Yamamoto T, Noda A, Nakazawa T, Hayashi K, et al. Short-term therapeutic effect of pancrelipase in patients with chronic pancreatitis. J Hepatobiliary Pancreat Cancer Res 2018;15:27-32.

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  

      • Cite
        CITE
        export Copy Download
        Close
        Download Citation
        Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

        Format:
        • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
        • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
        Include:
        • Citation for the content below
        Perioperative outcomes of older adult patients with pancreatic cancer based on nutritional status: a retrospective cohorat study
        Ann Clin Nutr Metab. 2025;17(1):66-74.   Published online April 1, 2025
        Close
      • XML DownloadXML Download
      Figure
      • 0
      • 1
      Related articles
      Perioperative outcomes of older adult patients with pancreatic cancer based on nutritional status: a retrospective cohorat study
      Image Image
      Fig. 1. CONUT value calculation table.
      Fig. 2. Long-term outcomes after pancreatic cancer resection in older adult (≥75 yeasr) and non-older (<75 years) patients. Comparing patients aged ≥75 years with those aged <75 years, the overall survival rate was significantly better in patients aged <75 years (P=0.002) (A). However, the two groups had no significant difference in recurrence-free survival (P=0.198) (B).
      Perioperative outcomes of older adult patients with pancreatic cancer based on nutritional status: a retrospective cohorat study
      <75 yr ≥75 yr P-value
      Sex (male:female) 253:174 69:53 0.594
      Preoperative CONUT value 2 (0-11) 3 (0-9) 0.260
      Preoperative PNI 44.3±6.0 43.0±5.7 0.032a
      Diabetes mellitus 220 (51.5) 61 (50.0) 0.837
      Hypertension 199 (46.6) 80 (65.5) <0.001a
      Preoperative chemotherapy 230 (53.8) 43 (35.3) <0.001a
      Stage of an illness 0 3 (0.7) 2 (1.6) 0.070
      IA 29 (6.8) 8 (6.6)
      IB 7 (1.6) 1 (0.8)
      IIA 98 (22.9) 43 (35.2)
      IIB 233 (54.6) 60 (49.2)
      III 5 (1.2) 0
      IV 52 (12.2) 8 (6.6)
      Operative procedure PD 248 (58.1) 61 (50.0)
      DP 118 (27.6) 51 (41.8) 0.007a
      TP 61 (14.3) 10 (8.2)
      Combined portal vein resection 172 (40.3) 33 (27.1) 0.008a
      Operation time (min) 534 (150–1,160) 481 (182–851) <0.001a
      Amount of blood loss (mL) 1,179 (22–7,250) 906 (63–9,695) <0.001a
      R0 resection 358 (83.8) 100 (82.0) 0.597
      <75 yr ≥75 yr P-value
      Postoperative hospital stay (day) 24 (5–193) 25 (3–415) 0.858
      Total complications 328 (76.8) 87 (71.3) 0.232
      Serious complications 121 (28.3) 36 (29.5) 0.820
      Death in hospital 11 (2.5) 4 (3.2) 0.752
      Readmission within 30 day 19 (15.5) 54 (12.6) 0.613
      SSI 106 (24.8) 36 (29.5) 0.294
      Organ space SSI 71 (16.6) 24 (19.6) 0.419
      Postoperative pancreatic fistula 56 (13.1) 25 (20.4) 0.058
      Postoperative pneumonia 21 (4.9) 13 (10.6) 0.020a
      Septicemia 26 (6.0) 6 (4.9) 0.826
      Thrombosis 22 (5.7) 7 (5.1) 0.818
      PNI≤40 PNI>40 P-value
      Sex (male:female) 24:12 45:41 0.165
      Hypertension 26 (72.2) 54 (62.8) 0.404
      Diabetes mellitus 19 (52.8) 42 (48.8) 0.842
      Preoperative chemotherapy 7 (19.4) 36 (41.8) 0.022a
      Operative procedure PD 21 (58.3) 40 (46.5) 0.536
      DP 14 (38.9) 37 (43.0)
      TP 1 (2.8) 9 (10.5)
      Combined portal vein resection 12 (33.3) 21 (24.4) 0.372
      Operation time (min) 502 (182–851) 470 (202–845) 0.306
      Amount of blood loss (mL) 1,222 (82–9,639) 834 (63–9,695) 0.149
      R0 resection 28 (77.8) 72 (83.7) 0.529
      PNI≤40 PNI>40 P-value
      Postoperative hospital stay (day) 27.5 (3–163) 24 (10–415) 0.355
      Total complications 28 (77.8) 59 (68.6) 0.382
      Serious complications 14 (38.9) 22 (25.6) 0.191
      Death in hospital 3 (8.3) 1 (1.2) 0.042a
      Readmission within 30 day 3 (8.3) 16 (18.6) 0.181
      SSI 12 (33.3) 24 (27.9) 0.663
      Organ space SSI 8 (22.2) 16 (18.6) 0.627
      Postoperative pancreatic fistula 7 (19.4) 18 (20.9) 0.852
      Postoperative pneumonia 6 (16.1) 7 (8.1) 0.200
      Septicemia 1 (2.7) 5 (5.8) 0.669
      Thrombosis 4 (11.1) 3 (3.5) 0.193
      No nutritional disorders Nutritional disorders P-value
      Sex (male:female) 48:43 21:10 0.207
      Hypertension 21 (67.7) 59 (64.8) 0.829
      Diabetes mellitus 17 (54.8) 44 (48.3) 0.677
      Preoperative chemotherapy 35 (38.5) 8 (25.8) 0.276
      Operative procedure PD 43 (47.2) 18 (58.1) 0.388
      DP 39 (42.9) 12 (38.7)
      TP 9 (9.9) 1 (3.2)
      Combined portal vein resection 24 (26.4) 9 (29.0) 0.816
      Operation time (min) 471 (202–845) 498 (182–851) 0.462
      Amount of blood loss (mL) 870 (63–9,695) 1,145 (82–9,639) 0.432
      R0 resection 76 (83.5) 24 (77.4) 0.565
      No nutritional disorders Nutritional disorders P-value
      Postoperative hospital stay (day) 24 (10–415) 28 (3–100) 0.085
      Total complications 61 (67.0) 26 (83.8) 0.106
      Serious complications 25 (27.5) 11 (35.5) 0.494
      Death in hospital 0 4 (12.9) <0.001a
      Readmission within 30 day 17 (18.7) 2 (6.5) 0.151
      SSI 25 (27.4) 11 (35.5) 0.494
      Organ space SSI 18 (19.8) 6 (19.4) 0.958
      Postoperative pancreatic fistula 20 (21.9) 5 (16.1) 0.799
      Postoperative pneumonia 8 (8.8) 5 (16.1) 0.312
      Septicemia 4 (4.4) 2 (6.4) 0.643
      Thrombosis 5 (5.5) 2 (6.5) 0.845
      Age Sex Technique PVR Blood loss (mL) Operation time (min) Postoperative pancreatic fistula PNI CONUT Cause of death
      1 76 Male DP None 9,639 453 Yes 37.1 5 Renal failure, pneumonia
      2 75 Male DP-CAR None 350 535 None 41.4 5 Pancreatic cancer liver metastasis
      3 79 Women SSPPD None 545 531 Yes 29.7 8 Sepsis
      4 82 Male SSPPD, right colon resection Yes 1,483 529 None 36.7 6 Sepsis, ARDS
      Table 1. Comparison of the background and intraoperative factors between the elderly and non-elderly patients

      Values are presented as median (range), mean±SD, or number (%).

      PNI, prognostic nutritional index; PD, pancreaticoduodenectomy; DP, distal pancreatectomy; TP, total pancreatectomy; SD, standard deviation.

      aStatistically significant differences.

      Table 2. Comparison of postoperative results between resected pancreatic cancer cases in elderly and non-elderly patients

      Values are presented as median (range) or number (%).

      SSI, surgical site infection.

      aStatistically significant differences.

      Table 3. Background and intraoperative factors of late-stage elderly pancreatic cancer cases grouped by PNI40

      Values are presented as number (%) or median (range).

      PNI, prognostic nutritional index; PD, pancreaticoduodenectomy; DP, distal pancreatectomy; TP, total pancreatectomy.

      aStatistically significant differences.

      Table 4. Postoperative outcomes of older adult patients with pancreatic cancer grouped by PNI40

      Values are presented as median (range) or number (%).

      PNI, prognostic nutritional index; SSI, surgical site infection.

      aStatistically significant differences.

      Table 5. Background and intraoperative factors of older adult patients with pancreatic cancer grouped by CONUT values

      Values are presented as number (%) or median (range).

      PD, pancreaticoduodenectomy; DP, distal pancreatectomy; TP, total pancreatectomy.

      Table 6. Postoperative outcomes of older adult patients with pancreatic cancer grouped by CONUT value

      Values are presented as median (range) or number (%).

      SSI, surgical site infection.

      aStatistically significant differences.

      Table 7. Pancreatic cancer in-hospital deaths in older adult patients

      PVR, portal vein combined resection; PNI, prognostic nutritional index; DP, distal pancreatectomy; DP-CAR, distal pancreatectomy with celiac axis resection; SSPPD, subtotal stomach-preserving pancreaticoduodenectomy; ARDS, acute respiratory distress syndrome.


      Ann Clin Nutr Metab : Annals of Clinical Nutrition and Metabolism
      Close layer
      TOP